Twice-daily cimetidine does not increase gastric bacterial flora

Area of Science:

• Gastroenterology
• Microbiology
• Pharmacology

Background:

• Peptic ulcer disease affects millions globally.
• Gastric acid suppression is a common treatment strategy.
• Concerns exist regarding potential bacterial overgrowth with acid suppression.

Purpose of the Study:

• To investigate the effect of cimetidine on gastric bacterial colonization in peptic ulcer patients.
• To assess changes in bacterial activity using glucose-hydrogen breath tests.

Main Methods:

• Thirty peptic ulcer patients (20 duodenal, 10 gastric) were enrolled.
• Patients received cimetidine (400 mg twice daily) for six weeks.
• Glucose-hydrogen breath tests were performed pre- and post-treatment.

Main Results:

• Basal breath hydrogen levels remained unchanged.
• Integrated hydrogen output over 2.5 hours showed no significant difference.
• Cimetidine treatment did not lead to detectable increases in gastric bacteria.

Conclusions:

• Six weeks of twice-daily cimetidine treatment did not result in significant gastric bacterial colonization.
• The study provides evidence against bacterial overgrowth as a major concern with this cimetidine regimen.